Literature DB >> 22398290

Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination.

P Shukla1, H T Nguyen, K Faulk, K Mather, U Torian, R E Engle, S U Emerson.   

Abstract

An infectious cDNA clone of a genotype 3 strain of hepatitis E virus adapted to growth in HepG2/C3A human hepatoma cells was constructed. This virus was unusual in that the hypervariable region of the adapted virus contained a 171-nucleotide insertion that encoded 58 amino acids of human S17 ribosomal protein. Analyses of virus from six serial passages indicated that genomes with this insert, although initially rare, were selected during the first passage, suggesting it conferred a significant growth advantage. RNA transcripts from this cDNA and the viruses encoded by them were infectious for cells of both human and swine origin, the major host species for this zoonotic virus. Mutagenesis studies demonstrated that the S17 insert was a major factor in cell culture adaptation. Introduction of 54 synonymous mutations into the insert had no detectable effect, thus implicating protein, rather than RNA, as the important component. Truncation of the insert by 50% decreased the levels of successful transfection by ~3-fold. Substitution of the S17 sequence by a different ribosomal protein sequence or by GTPase-activating protein sequence resulted in a partial enhancement of transfection levels, whereas substitution with 58 amino acids of green fluorescent protein had no effect. Therefore, both the sequence length and the amino acid composition of the insert were important. The S17 sequence did not affect transfection of human hepatoma cells when inserted into the hypervariable region of a genotype 1 strain, but this chimeric genome acquired a dramatic ability to replicate in hamster cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22398290      PMCID: PMC3347312          DOI: 10.1128/JVI.00146-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient.

Authors:  Toshinori Tanaka; Masaharu Takahashi; Hideyuki Takahashi; Koji Ichiyama; Yu Hoshino; Shigeo Nagashima; Hitoshi Mizuo; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

2.  Persistent carriage of hepatitis E virus in patients with HIV infection.

Authors:  Harry R Dalton; Richard P Bendall; Frances E Keane; Richard S Tedder; Samreen Ijaz
Journal:  N Engl J Med       Date:  2009-09-03       Impact factor: 91.245

3.  Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis.

Authors:  N Kamar; J Izopet; P Cintas; C Garrouste; E Uro-Coste; O Cointault; L Rostaing
Journal:  Am J Transplant       Date:  2010-03-19       Impact factor: 8.086

Review 4.  Chronic hepatitis E in liver transplant recipients: a significant clinical problem?

Authors:  S Pischke; H Wedemeyer
Journal:  Minerva Gastroenterol Dietol       Date:  2010-06

5.  Recombination analysis reveals a double recombination event in hepatitis E virus.

Authors:  Hua Wang; Wen Zhang; Bin Ni; Hongxing Shen; Yuyu Song; Xiaochun Wang; Shihe Shao; Xiuguo Hua; Li Cui
Journal:  Virol J       Date:  2010-06-14       Impact factor: 4.099

Review 6.  Zoonotic hepatitis E: animal reservoirs and emerging risks.

Authors:  Nicole Pavio; Xiang-Jin Meng; Christophe Renou
Journal:  Vet Res       Date:  2010-04-02       Impact factor: 3.683

7.  Deletions of the hypervariable region (HVR) in open reading frame 1 of hepatitis E virus do not abolish virus infectivity: evidence for attenuation of HVR deletion mutants in vivo.

Authors:  R S Pudupakam; Y W Huang; T Opriessnig; P G Halbur; F W Pierson; X J Meng
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

Review 8.  Hepatitis E virus: animal reservoirs and zoonotic risk.

Authors:  X J Meng
Journal:  Vet Microbiol       Date:  2009-03-20       Impact factor: 3.293

9.  ORF3 protein of hepatitis E virus is essential for virion release from infected cells.

Authors:  Kentaro Yamada; Masaharu Takahashi; Yu Hoshino; Hideyuki Takahashi; Koji Ichiyama; Shigeo Nagashima; Toshinori Tanaka; Hiroaki Okamoto
Journal:  J Gen Virol       Date:  2009-04-01       Impact factor: 3.891

10.  Hepatitis E virus genotype 3 diversity, France.

Authors:  Florence Legrand-Abravanel; Jean-Michel Mansuy; Martine Dubois; Nassim Kamar; Jean-Marie Peron; Lionel Rostaing; Jacques Izopet
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

View more
  93 in total

1.  Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.

Authors:  Nereida Jiménez de Oya; Estela Escribano-Romero; Ana-Belén Blázquez; María Lorenzo; Miguel A Martín-Acebes; Rafael Blasco; Juan-Carlos Saiz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Full-length sequence analysis of hepatitis E virus isolates: showing potential determinants of virus genotype and identity.

Authors:  Dong Yang; Mei Jiang; Min Jin; Zhigang Qiu; Weihong Cui; Zhiqiang Shen; Bo Li; Lianfeng Gong; Zhaoli Chen; Xinwei Wang; Jun-Wen Li
Journal:  Virus Genes       Date:  2013-07-26       Impact factor: 2.332

3.  Antiviral Candidates for Treating Hepatitis E Virus Infection.

Authors:  Natalie E Netzler; Daniel Enosi Tuipulotu; Subhash G Vasudevan; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

4.  Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipient.

Authors:  Vinaya C Maddukuri; Mark W Russo; William A Ahrens; Suzanne U Emerson; Ronald E Engle; Robert H Purcell; Eric B Thompson; Herbert L Bonkovsky
Journal:  Dig Dis Sci       Date:  2013-03-20       Impact factor: 3.199

5.  Potent Inhibition of Hepatitis E Virus Release by a Cyclic Peptide Inhibitor of the Interaction between Viral Open Reading Frame 3 Protein and Host Tumor Susceptibility Gene 101.

Authors:  Saumya Anang; Nidhi Kaushik; Smita Hingane; Anita Kumari; Jyoti Gupta; Shailendra Asthana; Baibaswata Nayak; C T Ranjith-Kumar; Milan Surjit
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

6.  Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems.

Authors:  Xianfang Wu; Viet Loan Dao Thi; Peng Liu; Constantin N Takacs; Kuanhui Xiang; Linda Andrus; Jérôme Gouttenoire; Darius Moradpour; Charles M Rice
Journal:  Gastroenterology       Date:  2017-12-24       Impact factor: 22.682

7.  ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.

Authors:  Harini Sooryanarain; Adam J Rogers; Dianjun Cao; Mary Etna R Haac; Yogesh A Karpe; Xiang-Jin Meng
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

8.  Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122.

Authors:  Bangari Haldipur; Prudhvi Lal Bhukya; Vidya Arankalle; Kavita Lole
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

9.  Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target.

Authors:  Changbo Qu; Shaoshi Zhang; Wenshi Wang; Meng Li; Yijin Wang; Marieke van der Heijde-Mulder; Ehsan Shokrollahi; Mohamad S Hakim; Nicolaas J H Raat; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  FASEB J       Date:  2018-08-02       Impact factor: 5.191

Review 10.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.